Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations trials recruiting in Ohio

Fewer than 3 recruiting trials found.

All Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations trials nationally

1

Recruiting in Ohio

3

Cities with sites

Cities in Ohio

Canton 1Columbus 1Toledo 1

Recruiting trials in Ohio

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
NCT05967689 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Canton, Columbus, Toledo

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.